Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

ClinicalTrials.gov ID: NCT00667173

Public ClinicalTrials.gov record NCT00667173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 8:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-Center, Evaluator-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-115 in the Treatment of Rosacea

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.

Study identification

NCT ID
NCT00667173
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dow Pharmaceutical Sciences
Industry
Enrollment
140 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Feb 20, 2012

2007 – 2008

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801 —
Therapeutics Clinical Research San Diego California 92123 —
Solano Clinical Research Vallejo California 94589 —
Cherry Creek Dermatology Research Inc. Denver Colorado 80246 —
FXM Research Corp. Miami Florida 33175 —
MedaPhase Inc. Newnan Georgia 30263 —
Henry Ford Medical Center Detroit Michigan 48202 —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
University Dermatology Consultants, Inc. Cincinnati Ohio 45219 —
DermResearch, Inc. Austin Texas 78759 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00667173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2012 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00667173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →